QTc prolongation as a surrogate for drug-induced arrhythmias: Fact or fallacy?

Acta Cardiologica

Volumn 66, Issue 6, 2011, Pages 685-689

  Hondeghem, Luc M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antiarrhythmica; Arrhythmias; QTc prolongation; Torsade de pointes; TRIaD

Indexed keywords

AMIODARONE; ENCAINIDE; FISH OIL; FLECAINIDE; LIDOCAINE; MORACIZINE; QUINIDINE;

ACTION POTENTIAL; ANTIARRHYTHMIC ACTIVITY; DISEASE MARKER; EDITORIAL; HEART ARRHYTHMIA; HEART MUSCLE REFRACTORY PERIOD; HEART PROARRHYTHMIA; HUMAN; PATIENT SAFETY; QT PROLONGATION; REFRACTORY PERIOD; TORSADE DES POINTES; TRIANGULATION;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART CONDUCTION SYSTEM; HUMANS; SODIUM CHANNEL BLOCKERS; TORSADES DE POINTES;

EID: 83755173195     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.6.2136950     Document Type: Editorial

References (32)

1. Dessertenne F. Ventricular tachycardia with 2 variable opposing foci [article in French]. Arch Mal Coeur Vess 1966; 59: 263-72.
2. Roden DM. Current status of class III antiarrhythmic drug therapy. Am J Cardiol 1993; 72: 50B-52B.
3. Lipicky RJ. A viewpoint on drugs that prolong the QTc interval. Am J Cardiol 1993; 72: 53B-54B.
4. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350: 1013-22.
5. Roden D. A practical approach to torsade de pointes. Clin Cardiol 1997; 20: 285-90.
6. http://www.fda.gov/RegulatoryInformation/Guidances/ucm129335.htm
7. Shah RR, Hondeghem LM. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD. Heart Rhythm 2005; 2: 758-72.
8. Morganroth J. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias. Am J Cardiol 1987; 60: 1276-81.
9. Lewis T, Drury AN. Revised views of the refractory period in relation to drugs reputed to pro-long it, and in relation to circus movement. Heart 1926; 13: 95-100.
10. Weidmann S. Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibers. J Physiol 1955; 129: 568-82.
11. Vaughan Williams EM. Chapter 2: Classification of Antiarrhythmic Agents. In Vaughan Williams EM, ed: Antiarrhythmic Drugs. Handbook of Experimental Pharmacology Series (No 89). Berlin: SpringerVerlag1989: pp. 45-67.
12. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-8.
13. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996; 348: 7-12.
14. Hondeghem LM. Antiarrhythmic agents: modulated receptor applications. Circulation 1987; 75: 514-20.
15. Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use-dependence. Circulation 1990; 81: 686-90.
16. Mason JW. Basic and clinical cardiac electrophysiology of encainide. Am J Cardiol 1986; 58: 18C-24C.
17. Campbell TJ, Vaughan Williams EM. Voltage-and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiovasc Res 1983; 17: 251-8.
18. Koller B, Franz MR. New classification of moricizine and propafenone based on electrophysiologic and electrocardiographic data from isolated rabbit heart. J Cardiovasc Pharmacol 1994; 24: 753-60.
19. Hondeghem LM, Katzung BG. Experimental test of a model of antiarrhythmic drug action: Effects of quinidine and lidocaine on myocardial conduction. Circulation 1980; 61: 1217-24.
20. Dujardin KS, Dumotier B, David M, Guizy M, Valenzuela C, Hondeghem LM. Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts. Am J Physiol Heart Circ Physiol 2008; 295: H1414-21.
21. Strauss HC, Bigger JT, Hoffman BF. Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res 1970; 26: 661-78.
22. Funck-Brentano C, Kibleur Y, Le Coz F, Poirier JM, Mallet A, Jaillon P. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation 1991; 83: 536-45.
23. Sager PT, Uppal P, Follmer C, Antimisiaris M., Pruitt C, Singh BN. Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation 1993; 8: 1063-71.
24. Bexton RS, Vallin H, Camm AJ. Diurnal variation of the QTc interval-influence of the autonomic nervous system. Br Heart J 1986; 55: 253-8.
25. Hondeghem L, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but APD prolongation is antiarrhythmic. Circulation 2001; 103: 2004-13.
26. Hondeghem LM, Dumotier B, Traebert M. Oscillations of cardiac wave length and proarrhythmia. Naunyn Schmiedebergs Arch Pharmacol 2010; 382: 367-76.
27. Hondeghem LM. QT and TdP. QT: an unreliable predictor of proarrhythmia. Acta Cardiol 2008; 63: 1-7.
28. Pratt CM, Ruberg S, Morganroth J, McNutt B, Woodward J, Harris S, Ruskin J, Moye L. Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability. Am Heart J 1996; 131: 472-80.
29. Hondeghem LM, Dujardin K, Hoffmann P, Dumotier B, De Clerck F. Drug-induced QTc prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine. J Cardiovasc Pharmacol 2011; 57: 589-97.
30. Hondeghem LM, Lu HR, van Rossem K, De Clerck F. Detection of proarrhythmia in the female rabbit heart: blinded validation. J Cardiovasc Electrophysiol 2003; 14: 287-94.
31. Mason JW, Hondeghem LM, Katzung BG. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 1984; 55: 278-85.
32. Sicouri S, Moro S, Litovsky S, Elizari MV, Antzelevitch C. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 1997; 8: 1269-79.